Diagnosis and therapy of multiple sclerosis

• 收藏
• 分享

专利权人:

Roberto Paterno;Vittorio Enrico Avvedimento;Luigi Michele Pavone;Mariarosaria Santillo

发明人:

Roberto Paterno,Mariarosaria Santillo,Vittorio Enrico Avvedimento,Luigi Michele Pavone

申请号：

US15192064

公开号：

US10633427B2

申请日:

2016.06.24

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The serotonin receptor 5HT2A (5HT2aR) and membrane NADPH oxidases (NOX enzymes) are found to be a target of autoantibodies present in Multiple Sclerosis patients. The present invention refers to peptides comprised in the extracellular regions of the human 5HT2aR and/or NOXs for diagnosis and therapy of Multiple Sclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/